Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Hypoglycemic Therapy in Type 2 Diabetes
NCT03804411Phase 4Unknown
- Start
- Aug 2017
- Primary completion
- Mar 2020
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin, sitagliptin, dapagliflozin, empagliflozin, liraglutide in type 2 diabetes mellitus (T2DM). Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03804411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804411.